Copeptin in Aortic Valve Replacement (CARE)

This study has been completed.
Information provided by (Responsible Party):
Deutsches Herzzentrum Muenchen Identifier:
First received: July 20, 2012
Last updated: NA
Last verified: July 2012
History: No changes posted

Copeptin is accepted as a marker of stress. We want to evaluate the preoperative and early postoperative copeptin leavens in patients undergoing different aortic valve procedures

Copeptin in Patients Undergoing Aortic Valve Replacement

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: GE DHM-AN-OR-2012/01

Further study details as provided by Deutsches Herzzentrum Muenchen:

Enrollment: 50
Study Start Date: May 2012

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients scheduled for surgical or transcatheter aortic valve replacement


Inclusion Criteria:

  • Patients undergoing surgical aortic valve replacment
  • Patients undergoing transcatheter aortic valve replacment

Exclusion Criteria:

  • denial by patient
  Contacts and Locations
Please refer to this study by its identifier: NCT01648647

Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München
Munich, Bavaria, Germany, D80636
Sponsors and Collaborators
Deutsches Herzzentrum Muenchen
  More Information

No publications provided

Responsible Party: Deutsches Herzzentrum Muenchen Identifier: NCT01648647     History of Changes
Other Study ID Numbers: GE DHM-AN-OR-2012/01
Study First Received: July 20, 2012
Last Updated: July 20, 2012
Health Authority: Germany: Ethikkommission der Fakultät für Medizin processed this record on April 15, 2014